Question 1

Who is the provider of NEXT FUNDS TOPIX 17 Pharmaceutical ETF?

Accepted Answer

NEXT FUNDS TOPIX 17 Pharmaceutical ETF is offered by NEXT FUNDS, a leading player in the field of passive investments.

Question 2

What is the ISIN of NEXT FUNDS TOPIX 17 Pharmaceutical ETF?

Accepted Answer

The ISIN of NEXT FUNDS TOPIX 17 Pharmaceutical ETF is JP3046600007.

Question 3

What is the Total Expense Ratio (TER) of NEXT FUNDS TOPIX 17 Pharmaceutical ETF?

Accepted Answer

The total expense ratio of NEXT FUNDS TOPIX 17 Pharmaceutical ETF is 0.32%, which means that investors pay 32 JPY per 10,000 JPY in investment capital annually.

Question 4

What currency is NEXT FUNDS TOPIX 17 Pharmaceutical ETF listed in?

Accepted Answer

The ETF is listed in JPY.

Question 5

What additional costs can European investors incur?

Accepted Answer

European investors may incur additional costs for currency exchange and transaction fees.

Question 6

Is NEXT FUNDS TOPIX 17 Pharmaceutical ETF UCITS-compliant?

Accepted Answer

No, NEXT FUNDS TOPIX 17 Pharmaceutical ETF does not comply with the EU UCITS investor protection directives.

Question 7

What is the price-earnings ratio (P/E) of NEXT FUNDS TOPIX 17 Pharmaceutical ETF?

Accepted Answer

The P/E ratio of NEXT FUNDS TOPIX 17 Pharmaceutical ETF is 21.64.

Question 8

Where is NEXT FUNDS TOPIX 17 Pharmaceutical ETF domiciled?

Accepted Answer

NEXT FUNDS TOPIX 17 Pharmaceutical ETF is domiciled in JP.

Question 9

When was NEXT FUNDS TOPIX 17 Pharmaceutical ETF launched?

Accepted Answer

The fund was launched on 3/21/2008.

Question 10

In which segment does NEXT FUNDS TOPIX 17 Pharmaceutical ETF primarily invest?

Accepted Answer

The NEXT FUNDS TOPIX 17 Pharmaceutical ETF mainly invests in Healthcare companies.

Question 11

What is the Net Asset Value (NAV) of NEXT FUNDS TOPIX 17 Pharmaceutical ETF?

Accepted Answer

The NAV of NEXT FUNDS TOPIX 17 Pharmaceutical ETF amounts to 33.09 B JPY.

Question 12

What is the Price-to-Book Ratio of NEXT FUNDS TOPIX 17 Pharmaceutical ETF?

Accepted Answer

The price-to-book ratio is 1.862.

Question 13

How can I invest in this ETF?

Accepted Answer

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

Question 14

How is the ETF traded?

Accepted Answer

The ETF is traded on the stock exchange, similar to stocks.

Question 15

Can I hold the ETF in my portfolio?

Accepted Answer

Yes, the ETF can be held in a regular securities account.

Question 16

Is the ETF suitable for short-term or long-term investments?

Accepted Answer

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

Question 17

How often is the ETF valued?

Accepted Answer

The ETF is valued on a daily stock exchange basis.

Question 18

Are there dividends for this ETF?

Accepted Answer

Information on dividends should be requested from the provider's website or your broker.

Question 19

What are the risks associated with this ETF?

Accepted Answer

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

Question 20

How transparent is the ETF regarding its investments?

Accepted Answer

The ETF is obligated to report regularly and transparently on its investments.

Question 21

How can I track the current performance of the ETF?

Accepted Answer

The performance can be viewed on Eulerpool or directly on the provider's website.

Question 22

Where can I find more information about the ETF?

Accepted Answer

Further information can be found on the official website of the provider.

NEXT FUNDS TOPIX 17 Pharmaceutical ETF